Federal Funding Opportunities

Winship investigators have access to an extensive listing of cancer-related funding issued by the National Institutes of Health and other federal agencies. The listing updates automatically on a daily basis.

Use the column sorting, search filtering, and pagination tools to find and select federal funding opportunities below.

Cascade Link
OpportunityPostedClosing

Emerging Science and Technology in Transplantation (U01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

05/11/2109/03/21

DOD Melanoma Translational Research Award

Agency: AMRAA

05/07/2108/26/21

DOD Melanoma Team Science Award

Agency: AMRAA

05/07/2108/26/21

DOD Melanoma Idea Award

Agency: AMRAA

05/07/2109/28/21

Technical Collaboration to Strengthen and Expand Capacity to Detect, Prevent, Respond and Mitigate the Effects of Public Health Threats of National and Global Importance with the Ministry of Public Health (MoPH) in the Kingdom of Thailand

Agency: CGH

05/05/2107/06/21

Coordinating Center for Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) in Cancer Survivors Consortium (U24 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

05/03/2107/14/21

Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) in Cancer Survivors Consortium (U01 Clinical Trial Required)

Agency: NIH

Institutions: NCI

05/03/2107/14/21

EARLY STAGE INNOVATIONS (ESI)

Agency: NASA

04/28/2106/28/21

Early Detection of Certain Medical Conditions Related to Environmental Health Hazards Supplement

Agency: ATSDR

04/27/2106/26/21

DoD Breast Cancer, Breakthrough Award Levels 1 and 2

Agency: AMRAA

04/26/2109/14/21

DoD Breast Cancer, Era of Hope Scholar Award

Agency: AMRAA

04/26/2109/14/21

DoD Breast Cancer, Breakthrough Award Level 3

Agency: AMRAA

04/26/2110/05/21

DoD Breast Cancer, Breakthrough Award Level 4

Agency: AMRAA

04/26/2110/05/21

DoD Breast Cancer, Innovator Award

Agency: AMRAA

04/26/2110/05/21

DoD Breast Cancer, Transformative Breast Cancer Research Award

Agency: AMRAA

04/26/2110/05/21

DoD Kidney Cancer, Idea Development Award

Agency: AMRAA

04/23/2110/05/21

DoD Kidney Cancer, Translational Research Partnership Award

Agency: AMRAA

04/23/2110/05/21

DoD Kidney Cancer, Concept Award

Agency: AMRAA

04/23/2107/13/21

DoD Kidney Cancer, Postdoctoral and Clinical Fellowship Award

Agency: AMRAA

04/23/2107/13/21

Expanding the National Approach to Chronic Disease Education and Awareness

Agency: NCCDPHP

04/20/2106/21/21

Building Interdisciplinary Research Careers in Women's Health Program (BIRCWH) (K12 Clinical Trial Optional)

Agency: NIH

Institutions: ORWHNCINIANIAAANIAIDNICHDNIDCRNIDANIEHS

04/16/2106/11/21

3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

04/14/2111/22/21

Emergency Awards: Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations RADx-UP Phase II (U01 Clinical Trial Optional)

Agency: NIH

Institutions: ODNEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHNCATSNCITHROODPOBSSRSGMROORWHECHO

04/13/2107/07/21

Emergency Award: RADx-UP - Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trials Optional)

Agency: NIH

Institutions: ODNEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHNCATSNCITHROODPOBSSRSGMROORWHECHO

04/13/2107/07/21

Centers on Telehealth Research for Cancer-Related Care (P50 Clinical Trial Required)

Agency: NIH

Institutions: NCI

04/08/2107/20/21

DoD Prostate Cancer, Data Science Award

Agency: AMRAA

04/08/2107/29/21

DoD Prostate Cancer, Health Equity Research and Outcomes Improvement Consortium Award

Agency: AMRAA

04/08/2107/29/21

DoD Prostate Cancer, Clinical Consortium Award

Agency: AMRAA

04/08/2109/23/21

DoD Prostate Cancer, Idea Development Award

Agency: AMRAA

04/05/2109/23/21

DoD Prostate Cancer, Health Disparity Research Award

Agency: AMRAA

04/05/2107/29/21

DoD Prostate Cancer, Translational Science Award

Agency: AMRAA

04/05/2107/29/21

Proteogenomic Translational Research Centers (PTRCs) for Clinical Proteomic Tumor Analysis Consortium (U01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

04/05/2107/30/21

Proteogenomic Data Analysis Centers (PGDACs) for Clinical Proteomic Tumor Analysis Consortium (U24 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

04/05/2106/30/21

Proteome Characterization Centers (PCCs) for Clinical Proteomic Tumor Analysis Consortium (U24 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

04/05/2106/30/21

DoD Prostate Cancer, Early Investigator Research Award

Agency: AMRAA

04/05/2107/01/21

DoD Prostate Cancer, Physician Research Award

Agency: AMRAA

04/05/2107/01/21

Limited Competition Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDA

04/02/2108/09/21

Radiation-Induced Immune Dysfunction (U01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

04/02/2108/24/21

Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth) Research Training (Collaborative U2R Clinical Trial Optional)

Agency: NIH

Institutions: FICNCINIANIEHSORWH

03/26/2107/08/21

Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth) Research (Collaborative U01 Clinical Trial Optional)

Agency: NIH

Institutions: FICNCINIANIEHSORWH

03/26/2107/08/21

SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

03/25/2108/06/21

CDMRP Ovarian Cancer Omics Consortium Award

Agency: AMRAA

03/25/2107/08/21

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINIDCR

03/25/2101/07/24

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)

Agency: NIH

Institutions: NCI

03/25/2101/07/24

DoD Peer Reviewed Cancer, Translational Team Science Award

Agency: AMRAA

03/24/2108/18/21

DoD Peer Reviewed Cancer, Behavioral Health Science Award

Agency: AMRAA

03/24/2108/18/21

DoD Peer Reviewed Cancer, Career Development Award

Agency: AMRAA

03/24/2108/18/21

DoD Peer Reviewed Cancer, Idea Award

Agency: AMRAA

03/24/2109/08/21

DoD Peer Reviewed Cancer, Impact Award

Agency: AMRAA

03/24/2109/08/21

Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIMHDNEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNCCIHNCIODODPOBSSRSGMROORWH

03/23/2108/24/21

Research on Bat Immunology (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

03/18/2103/15/22

Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

03/18/2111/17/23

Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIGMSNEINHGRINIANIAAANIAIDNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNINDSNINRNCI

03/18/2101/07/24

Radiation Health Protection Involving Ionizing and Non-Ionizing Radiation

Agency: NCEH

03/16/2105/17/21

Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 - Independent Clinical Trial Not Allowed)

Agency: NIH

Institutions: OBSSRNEINIAAANICHDNIDDKNIDANIEHSNIMHNCCIHNCIODPORWH

03/15/2106/04/21

The NCI Transition Career Development Award (K22 Independent Basic Experimental Studies with Humans Required)

Agency: NIH

Institutions: NCI

03/15/2103/14/24

The NCI Transition Career Development Award (K22 - Independent Clinical Trial Required)

Agency: NIH

Institutions: NCI

03/15/2103/14/24

The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

03/15/2103/14/24

Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

03/12/2103/07/24

DoD Gulf War Illness, Idea Award

Agency: AMRAA

03/11/2108/19/21

DoD Gulf War Illness, Research Advancement Award

Agency: AMRAA

03/11/2108/19/21

DoD Gulf War Illness, New Investigator Award

Agency: AMRAA

03/11/2108/19/21

HEAL Initiative: Analgesic Development Initial Translational Efforts [Small Molecules and Biologics] (U19 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NINDSNEINIANIAAANIAMSNICHDNIDCRNIMHNCATSNCCIH

03/11/2110/10/23

Maximizing the Scientific Value of Existing Biospecimen Collections (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINHLBINIAAANIDANIEHSCTPODP

03/10/2103/08/23

DoD Lung Cancer, Idea Development Award

Agency: AMRAA

03/08/2107/28/21

DoD Lung Cancer, Clinical Translational Research Partnership Award

Agency: AMRAA

02/26/2107/28/21

DoD Lung Cancer, Investigator-Initiated Translational Research Award

Agency: AMRAA

02/26/2107/28/21

Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

02/19/2106/02/21

ROSES 2021: Arctic Radiation-Cloud-Aerosol-Surface Interaction Experiment

Agency: HQ

02/12/2110/15/21

NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIHNEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNIMHDNLMNCCIHNCATSORIPNCI

02/10/2101/07/24

Human Immunology Project Consortium (U19 Clinical Trial Optional)

Agency: NIH

Institutions: NIAID

02/08/2106/04/21

Human Immunology Project Consortium (HIPC) Coordinating Center (U01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

02/08/2106/04/21

Expert-Driven Small Projects to Strengthen Gabriella Miller Kids First Discovery (R03 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NICHD

02/08/2106/18/21

CDMRP Ovarian Cancer Proteogenomics Research Award

Agency: AMRAA

02/08/2107/08/21

CDMRP Ovarian Cancer Clinical Translational Research Award

Agency: AMRAA

02/08/2107/08/21

CDMRP Ovarian Cancer Investigator-Initiated Research Award

Agency: AMRAA

02/08/2107/08/21

CDMRP Ovarian Cancer, Ovarian Cancer Academy Award

Agency: AMRAA

02/08/2107/08/21

CDMRP Ovarian Cancer Pilot Award

Agency: AMRAA

02/08/2107/08/21

Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

01/12/2106/18/21

Immune Development in Early Life (IDEaL) (U01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAIDNIEHS

01/12/2106/18/21

Limited Competition: Specific Pathogen Free Macaque Colonies (U42 Clinical Trial Not Allowed)

Agency: NIH

Institutions: ORIP

01/08/2101/07/24

Cyber-Physical Systems

Agency: NSF

01/08/2112/31/21

DoD Breast Cancer, Breakthrough Award Level 4

Agency: AMRAA

01/06/2106/23/21

DoD Breast Cancer, Breakthrough Award Level 3

Agency: AMRAA

01/06/2106/23/21

DoD Breast Cancer, Transformative Breast Cancer Consortium Award

Agency: AMRAA

01/06/2106/23/21

DoD Breast Cancer, Innovator Award

Agency: AMRAA

01/06/2106/23/21

International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed

Agency: NIH

Institutions: FICNCI

01/04/2103/08/23

International Research Scientist Development Award (IRSDA) (K01 Independent Clinical Trial Required)

Agency: NIH

Institutions: FICNCI

01/04/2103/08/23

Music and Health: Understanding And Developing Music Medicine (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NINDSNEINIANIAAANIDCRNIDANIMHNINRNIMHDNCCIHNCIOBSSR

12/23/2002/05/23

Aging Effects on Osteoimmunology (R01 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NIA

12/10/2006/15/21

Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/02/2011/18/21

Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/02/2011/17/21

Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/02/2011/17/21

Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/02/2011/17/21

Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/02/2011/17/21

Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional)

Agency: NIH

Institutions: NCI

12/02/2011/17/21

Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional)

Agency: NIH

Institutions: NCI

12/02/2011/17/21

Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/24/2009/29/21

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/24/2009/29/21

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/24/2009/29/21

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/24/2009/29/21

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/24/2009/29/21

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/24/2009/29/21

Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIANIAMSNIDCRNIDDKNIMHNINDSNCI

11/23/2001/07/24

Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NIANIAMSNIDCRNIDDKNINDSNCI

11/23/2001/07/24

Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

11/20/2009/28/21

Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science

Agency: NSF

11/20/2011/10/21

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

11/20/2009/29/21

Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

11/20/2009/29/21

Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

11/20/2009/29/21

Reproducible Cells and Organoids via Directed- Differentiation Encoding

Agency: NSF

11/20/2005/18/21

Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

11/17/2001/07/24

Cancer Research Education Grants Program - Curriculum or Methods Development (R25 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

11/17/2001/07/24

Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

11/17/2001/07/24

Addressing Health Disparities among Immigrant Populations through Effective Interventions (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIMHDNIAAANIEHSNCIOBSSR

11/17/2001/07/23

Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01 Clinical trial not allowed)

Agency: NIH

Institutions: NIMHDNIANIAAANIEHSNCI

11/17/2001/07/23

Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPSGMRO

11/16/2005/07/23

Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIDANIAAANCI

11/16/2011/15/23

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

Agency: NIH

Institutions: NCI

11/12/2001/07/24

Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

Agency: NIH

Institutions: NCI

11/10/2001/07/24

Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINCCIHNEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIMHNIMHDNINDSNINRNLMORIPORWH

11/09/2012/28/23

Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Humans Required)

Agency: NIH

Institutions: NCINCCIHNEINIANIAAANIAMSNICHDNIDCDNIDCRNIDANIEHSNIMHNIMHDNINDSNINRNLMORWH

11/09/2012/28/23

Limited Competition: Lasker Clinical Research Scholars Transition Award (R00 Clinical Trial Optional)

Agency: NIH

Institutions: NCINHLBINIAAANIAIDNIDDK

11/05/2009/30/23

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity)

Agency: NIH

Institutions: NCCIHNCINEINHGRINHLBINIANIAAANIAIDNIAMSNICHDNIDCDNIDCRNIDDKNIEHSNIMHNIMHDNINRNINDSNLMORIPNIDANIBIBNIGMS

10/28/2009/07/23

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)

Agency: NIH

Institutions: NCCIHNCINEINHGRINHLBINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIEHSNIGMSNIMH

10/26/2009/07/23

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)

Agency: NIH

Institutions: NCCIHNCINEINHLBINIANIAAANIAIDNICHDNIDCDNIDCRNIDDKNIEHSNIMHORIP

10/26/2009/07/23

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)

Agency: NIH

Institutions: NCCIHNCINHLBINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIEHSNIGMSNIMHNINDSNLMORIP

10/26/2012/08/23

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)

Agency: NIH

Institutions: NCCIHNCINEINHGRINHLBINIANIAAANIAIDNIAMSNICHDNIDCDNIDCRNIDDKNIEHSNIMHNIMHDNINRNINDSNLMORIP

10/21/2009/07/23

Integrated University Program – Scholarship and Fellowship Support

Agency: ID

10/15/2010/14/30

Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPODPOBSSRODSORWH

10/13/2010/07/23

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

10/13/2010/10/23

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

10/13/2010/10/23

Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2021, 2022, and 2023 (P50 Clinical Trial Required)

Agency: NIH

Institutions: NCINIDCR

09/28/2001/07/24

Department of Defense HIV/AIDS Prevention Program

Agency: AMRAA

09/24/2009/23/22

Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

09/23/2012/14/21

Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations (R01 Clinical Trial Required)

Agency: NIH

Institutions: NCIODP

09/15/2001/18/22

Tobacco Control Policies to Promote Health Equity (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCIODP

09/04/2009/07/23

Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCIODP

09/04/2009/07/23

Clinical Translation of Activated Optical Fluorescence Methods and Technologies for Sensitive Cancer Detection in Vivo (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/28/2010/13/21

NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/24/2007/20/22

Research to Improve Native American Health (R21 Clinical Trials Optional)

Agency: NIH

Institutions: NIDANIAAANIAMSNIDCRNIEHSNIMHNINRNIMHDNLMNCCIHNCATSNCIOBSSR

08/17/2009/07/23

Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIDANHLBINIAAANIAIDNIAMSNIBIBNIDCRNIEHSNIMHNINRNIMHDNLMNCIOBSSR

08/17/2009/07/23

Innovative Research in Cancer Nanotechnology (IRCN) (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

08/13/2005/04/23

Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

08/05/2011/09/22

2020 Human Exploration Research Opportunities (HERO)

Agency: JSC

07/31/2007/30/21

Investigator-Initiated Research on Genetic Counseling Processes and Practices (R01, Clinical Trial Optional)

Agency: NIH

Institutions: NCINHGRI

07/30/2007/08/21

Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed)

Agency: NIH

Institutions: ODSNCINIDDKNIEHSNCCIH

07/30/2004/15/22

Ethical, Legal and Social Implications (ELSI) (Research R01 Clinical Trial Optional)

Agency: NIH

Institutions: NHGRINCINEINHLBINIANIEHSNIMHNIMHDNINDSOBSSR

07/28/2007/19/23

Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21) (Clinical Trial Optional)

Agency: NIH

Institutions: NHGRINCINEINIANIEHSNIMHNINDSOBSSR

07/28/2007/19/23

Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03) Clinical Trial Optional)

Agency: NIH

Institutions: NHGRIFICNCINIANIEHSNIMHOBSSR

07/28/2007/19/23

Fertility Status as a Marker for Overall Health (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NICHDNIEHSNCIODPORWH

07/23/2006/19/23

Fertility Status as a Marker for Overall Health (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NICHDNIEHSNCIODPORWH

07/23/2006/19/23

Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINHGRINIDCR

07/22/2009/07/22

Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCINHGRINIDCR

07/22/2009/07/22

Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINIDCDNIMH

07/20/2001/07/23

Promoting Research on Music and Health: Phased Innovation Award for Music Interventions (R61/R33 Clinical Trial Optional)

Agency: NIH

Institutions: NCCIHNIANIAAANIMHNCIOBSSR

07/15/2006/19/23

SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAMSNIBIBNIDCDNIDCRNIDDKNIEHSNIGMSNIMHNLMNCCIHNCATS

07/10/2004/05/22

Administrative Supplement for Research on Dietary Supplements (Admin Supp-Clinical Trial Not Allowed)

Agency: NIH

Institutions: ODSNCINEINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIEHSNIMHDFICNCCIHORIP

06/09/2004/15/23

Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 Basic Experimental Studies with Humans Required)

Agency: NIH

Institutions: OPPNETNIAAANIEHSNIMHNIMHDNCCIHNCIOBSSR

06/03/2003/17/23

Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 No Independent Clinical Trials)

Agency: NIH

Institutions: OPPNETNIAAANIEHSNIMHNIMHDNCCIHNCIOBSSR

06/03/2003/17/23

NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)

Agency: NIH

Institutions: NCCIHODS

05/20/2005/07/23

NCCIH Natural Product Mid Phase Clinical Trial Cooperative Agreement (U01 Clinical Trial Required)

Agency: NIH

Institutions: NCCIH

05/20/2005/07/23

Metastasis Research Network (U54 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

05/13/2005/28/21

Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required)

Agency: NIH

Institutions: NCCIHNCINHLBINHGRINIANIAAANIBIBNICHDNIDCDNIDCRNIDANIMHNINDSNIEHSNIMHD

05/12/2005/07/23

Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)

Agency: NIH

05/12/2005/07/23

NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIHNEINHGRINIANIAAANIAIDNIAMSNIDCDNIDCRNIDANIEHSNINRNIMHDNLMNCCIHNCIICs

05/07/2005/07/23

NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required)

Agency: NIH

Institutions: NCINHLBINHGRINIANIAAANIAMSNIBIBNICHDNIDANCCIHNIDDKNIEHSNIMHNINDSNINRNIMHD

05/05/2005/07/23

NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIHNEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHORIPNCIICs

05/05/2005/07/23

NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies with Humans Required)

Agency: NIH

Institutions: NCINEINIANIAAANICHDNIDCDNIDCRNIDANIEHSNIMHNIMHDNINDSNINRNCCIH

05/05/2005/07/23

NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAMSNIAIDNIBIBNCCIHNICHDNIDANIDCDNIDCRNIDDKNIEHSNIGMSNIMHNINDSNINRNLMORIPNIMHD

05/05/2005/07/23

Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional)

Agency: NIH

Institutions: ODPNIANIDCDNIDANIMHNINRNIMHDNCCIHNCIOBSSR

04/30/2009/07/23

Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity (R01 Clinical Trial Optional)

Agency: NIH

Institutions: ODPNIANIDCDNIDCRNCCIHNCI

04/30/2009/07/23

Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional)

Agency: NIH

Institutions: NIMHDNIANIDANCI

04/20/2009/07/23

New Informatics Tools and Methods to Enhance U.S. Cancer Surveillance Research (U01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

04/15/2006/06/23

Strengthening Institutional Capacity to Conduct Global Cancer Research in Low- and Middle-Income Countries (D43 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

04/14/2006/24/21

Cyber-Physical Systems

Agency: NSF

04/07/2012/01/21

Mechanisms and Consequences of Sleep Disparities in the U.S. (R01 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIMHDNHLBINIANIAAANINDSNCI

04/03/2007/14/22

Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIBIBNIDCR

03/30/2009/07/22

NIDA Small Research Grant Program (R03 Clinical Trial Required)

Agency: NIH

Institutions: NIDA

03/24/2005/07/23

Exploiting in vivo or in situ imaging approaches to understand HIV-relevant processes in the context of substance use disorders (R61/R33 Clinical Trials Optional)

Agency: NIH

Institutions: NIDA

03/24/2008/13/21

Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)

Agency: NIH

Institutions: NCINEINHGRINHLBINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDDKNIDANIEHSNIGMSNIMHNINRNCCIHORIP

03/20/2005/25/23

Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

03/16/2007/30/21

Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

03/16/2007/30/21

Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

03/12/2005/07/23

Gastrointestinal (GI) and Microbiome Explorers: Development of Swallowable Smart Pills or Devices for Precision Nutrition, Microbiome and Digestive Disease Applications (R21/R33 Clinical Trial Required)

Agency: NIH

Institutions: NIDDKNCI

03/11/2006/08/21

Development of Wearable Smart Devices for Continuous Monitoring of Circulating Nutrients, Metabolites and Hormones (R21/R33 Clinical Trial Required)

Agency: NIH

Institutions: NIDDKNCI

03/11/2006/08/21

Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)

Agency: NIH

Institutions: NCINCCIHNHGRINIAIDNICHDNIDDKNIEHSNIGMSNIMH

03/10/2009/07/25

Research Towards Developing a Cure for HBV in HIV/HBV Co-Infection (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

03/06/2001/07/22

Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional)

Agency: NIH

Institutions: NIGMSNCINHLBINHGRINIANIAIDNIAMSNIDCRNIDDKNIDANIMHDNCCIHORWH

03/05/2007/23/21

Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/24/2011/18/21

Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAIDNCINHLBINIANICHDNIDCRNIDDKNIDANIMHNINRNIMHDFIC

02/03/2007/28/22

Centers for AIDS Research (P30 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAIDNCINHLBINIANICHDNIDCRNIDDKNIDANIMHNINRNIMHDFIC

02/03/2007/28/22

National Cancer Institute Program Project Applications (P01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/27/2005/07/23

Genomic Expert Curation Panels (U24 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NICHDNEINIMHNINDSNCI

01/23/2005/26/22

Biomedical Knowledgebase (U24 - Clinical Trials Not Allowed)

Agency: NIH

Institutions: NIGMSNIAAANIAIDNIDANIEHSNINDSNIMHDNCI

01/17/2005/08/23

Biomedical Data Repository (U24 - Clinical Trials Not Allowed)

Agency: NIH

Institutions: NIGMSNIAAANIAIDNIDANIEHSNINDSNIMHDNCI

01/17/2005/08/23

Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01- Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIMHDNCI

01/14/2004/01/22

Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21- Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIMHDNCI

01/14/2004/01/22

Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

12/10/1910/28/22

NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

12/09/1909/07/22

Co-infection and Cancer (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

11/22/1901/07/23

Co-infection and Cancer (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

11/22/1901/07/23

NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

11/22/1901/07/23

Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

11/12/1901/07/23

NCI Small Grants Program for Cancer Research for Years 2020, 2021, and 2022 (NCI Omnibus R03 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/08/1901/07/23

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/04/1909/25/22

Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

10/18/1901/07/23

Integrative Research on Polysubstance Abuse and Disorder (R61/R33 Clinical Trial Optional)

Agency: NIH

Institutions: NIDANCI

10/18/1911/07/22

HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NINDSNEINHLBINIANIAAANIAMSNIBIBNICHDNIDCRNIDDKNIGMSNIMHNINRNIMHDNLMNCCIHNCATSORIPNCI

10/04/1909/08/22

HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required)

Agency: NIH

Institutions: NINDSNEINHLBINIANIAAANIBIBNICHDNIDDKNIGMSNIMHNINRNIMHDNCCIHNCI

10/04/1909/08/22

HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required)

Agency: NIH

Institutions: NINDSNEINHLBINIANIAAANIBIBNICHDNIDDKNIGMSNIMHNINRNIMHDNCCIHNCI

10/04/1909/08/22

HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NINDSNEINHLBINIANIAAANIAMSNIBIBNICHDNIDCRNIDDKNIGMSNIMHNINRNIMHDNLMNCCIHNCATSORIPNCI

10/04/1909/08/22

Perception and Cognition Research to Inform Cancer Image Interpretation (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

10/02/1901/07/23

Perception and Cognition Research to Inform Cancer Image Interpretation (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIBIB

10/02/1901/07/23

Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NICHDNHLBINIDCRNCI

09/12/1901/07/23

Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38) (Clinical Trial Not Allowed)

Agency: NIH

Institutions: NHLBINCINIANIAID

09/09/1901/14/22

Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIDANIAAA

09/09/1909/07/21

Revision Applications for Mechanisms of Drug Resistance (U54 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

09/06/1906/23/21

Revision Applications for Mechanisms of Drug Resistance (P01 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

09/05/1906/23/21

Revision Applications for Mechanisms of Drug Resistance (P50 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

09/05/1906/23/21

Revision Applications for Mechanisms of Drug Resistance (R01 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

09/05/1906/23/21

Revision Applications for Mechanisms of Drug Resistance (U01 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

09/05/1906/23/21

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

09/05/1909/07/21

Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

09/03/1901/10/22

Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

09/03/1901/10/22

Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic Development and Mechanisms of Resistance (U01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

08/29/1903/11/22

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/29/1909/07/22

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/29/1909/07/22

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/29/1909/07/22

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/29/1909/07/22

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/29/1907/16/22

Neural Regulation of Cancer (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

08/28/1905/27/22

Neural Regulation of Cancer (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

08/28/1905/27/22

Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/16/1906/08/22

Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/16/1906/08/22

Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/12/1906/08/22

Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/12/1906/08/22

Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

07/30/1902/11/22

Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

06/28/1909/07/22

Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R33 Clinical Trial Optional)

Agency: NIH

Institutions: NIA

06/25/1907/16/22

Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R21/R33 Clinical Trial Optional)

Agency: NIH

Institutions: NIA

06/25/1907/16/22

Research Projects in Cancer Systems Biology (U01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

05/22/1911/15/21

Postdoctoral Research Associate Training (PRAT) Program (Fi2)

Agency: NIH

Institutions: NIGMS

05/21/1910/04/21

Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional)

Agency: NIH

Institutions: FICNCINIDANIMH

05/14/1908/20/21

Exploratory Grants in Cancer Epidemiology (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

05/08/1910/08/21

Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINHGRINIANIAAANICHDNIDCRNIDANIEHSNIMHNINDSFICODPOBSSRORWH

05/08/1905/07/22

Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINHLBINHGRINIANIAAANIAIDNIAMSNICHDNIDCDNIDCRNIDANIEHSNIMHNINDSNINRNIMHDNCCIHODPOBSSRORWH

05/08/1905/07/22

Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCINHGRINIANIAAANIAIDNIAMSNIDCDNIDANIEHSNIMHNINDSNINRFICNCCIHODPOBSSRORWH

05/08/1905/07/22

Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

05/01/1912/10/21

Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIEHS

04/11/1911/08/21

Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIEHS

04/11/1911/08/21

Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

04/08/1906/17/21

Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCCIHNCINIANIAAANIDANIDCRNINDSNINROBSSRORWH

02/28/1905/07/22

Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCCIHNCINHLBINIANIAAANIDANIDCRNINDSNINROBSSRORWH

02/28/1905/07/22

Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/27/1911/08/21

Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/27/1911/08/21

Microbial-based Cancer Therapy -Bugs as Drugs (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/22/1905/07/22

Microbial-based Cancer Therapy -Bugs as Drugs (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/22/1905/07/22

Biology of Bladder Cancer (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

02/05/1905/07/22

Biology of Bladder Cancer (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

02/05/1905/07/22

Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDANIMHDNIMHNCINCCIHORWH

01/09/1909/07/21

Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDANINDSNIMHDNIMHNCINICHDORWH

01/09/1909/07/21

Bioengineering Research Grants (BRG) (R01 Clinical Trial Required)

Agency: NIH

Institutions: NIBIBNCINIANIAAANINDSNEI

01/08/1905/07/22

Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIBIBNIAAANIAMSNCINIDCRNIEHSNINDSNIA

01/08/1901/07/22

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/08/1901/07/22

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINIAMS

01/08/1901/07/22

End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCI

01/08/1901/07/22

Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Required)

Agency: NIH

Institutions: NICHDNEININRNIDCDNIDANINDSNHLBINCINIANIMH

12/21/1801/07/22

End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCI

12/21/1801/07/22

Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)

Agency: NIH

Institutions: NINRNCINIANICHDNIDCDNIDANIMHNINDSNHLBI

12/21/1801/07/22

Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDCRNCINHLBINIANIAIDNIAMSNIBIBNICHDNIDCDNIDANIEHSNIMHNINDSNCCIHNINR

12/21/1801/07/22

Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/17/1801/07/22

Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/17/1801/07/22

Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/17/1801/07/22

Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R43/R44 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDCRNCINIMHNLMNCATS

10/24/1809/05/21

Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R41/R42 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDCRNCINIMHNLMNCATS

10/24/1809/05/21

Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCINCCIHOBSSR

10/01/1801/07/22

Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCINCCIHOBSSR

10/01/1801/07/22

Biobehavioral Basis of Chronic Pain (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCINIAMSNCCIHOBSSR

10/01/1801/07/22

Biobehavioral Basis of Chronic Pain (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCINIAMSNCCIHOBSSR

10/01/1801/07/22

Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

09/28/1807/11/21

Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional)

Agency: NIH

Institutions: ODPNCINIANIAAANIDCRNIDANIMHNIMHD

09/21/1801/07/22

Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 - Clinical Trial Optional)

Agency: NIH

Institutions: NIDANCINCCIHNIAAANICHD

09/10/1809/07/21

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

09/07/1808/11/21

Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINCCIHODS

08/14/1809/07/21

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/07/1809/07/21

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/07/1809/07/21

Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDCRNCINIAMSNIDAODS

07/25/1809/07/21

Biologic Factors Underlying Dental, Oral, and Craniofacial Health Disparities (R21 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDCRNIMHD

07/25/1809/07/21

Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDDKNCINIAAANIMHDNCCIH

07/17/1809/07/21

Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDDKNCINIAAANIMHDNINR

07/17/1809/07/21

Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDDKNCINICHDODPOBSSR

07/12/1809/10/21

Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01 - Clinical Trial Optional)

Agency: NIH

Institutions: ODPNCINIDCRNIDANIMHD

06/29/1806/15/21

Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: ODPNCINIDCRNIDANIEHS

06/29/1806/15/21

Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R21 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: ODPNCINIDCRNIDANIEHS

06/29/1806/25/21

Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R21 - Clinical Trial Optional)

Agency: NIH

Institutions: ODPNCINIDCRNIDANIMHD

06/29/1806/25/21

Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (U24 - Clinical Trial Optional)

Agency: NIH

Institutions: NCI

06/28/1806/14/21

Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINEINHGRINIANIAAANIAIDNIBIBNIDCRNIDANIGMSNINDSNINRNIMHDNCCIHNCATS

06/20/1809/04/21

The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NICHDNCINEI

06/14/1806/03/21

Precision Imaging of Oral Lesions (R01- Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDCRNIBIBNCI

05/16/1809/07/21

SBIR Technology Transfer (R43/R44 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NINDSNCINEINIAAANIDCRNIDANINR

03/06/1809/05/21

Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed )

Agency: NIH

Institutions: ORWHNCINEINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHORIP

01/25/1809/07/21

Change of Grantee Organization (Type 7 Parent Clinical Trial Optional)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPOBSSRORWH

01/25/1806/30/21

Fundamental Research to Counter Weapons of Mass Destruction

Agency: DTRA

03/20/1509/30/24
  TOP